Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Transplantation|January 1, 1990
Evidence that glucocorticosteroids block expression of the human interleukin-6 gene by accessory cellsB Zanker, G Walz, K J Wieder, et al.
Transplantation|January 1, 1990
Possible association of the immunosuppressive and B cell lymphoma-promoting properties of cyclosporineG Walz, B Zanker, L B Melton, et al.
Transplantation|September 1, 1993
Evidence that functional deletion of donor-reactive T lymphocytes in kidney allograft recipients can occur at the level of cytotoxic T cells, IL-2-producing T cells, or both. A limiting dilution studyB Zanker, J Jooss-Rüdiger, H E Franz, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 17, 1998
Aggressive treatment of the first acute rejection episode using first-line anti-lymphocytic preparation reduces further acute rejection episodes after human kidney transplantationJ Theodorakis, H Schneeberger, W D Illner, et al.
Kidney International|December 1, 1996
Restricted T cell V beta repertoire in renal allografts during acute and chronic rejectionC Barth, A Von Menges, B Zanker, et al.
European Journal of Immunology|January 1, 1986
An inherited deficiency of the third component of complement, C3, in guinea pigsR Burger, J Gordon, G Stevenson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1990
Transcriptional modulation of human IL-6 gene expression by verapamilG Walz, B Zanker, C Barth, et al.
Transplantation|March 1, 1987
Selective reduction of donor-specific cytotoxic T lymphocyte precursors in patients with a well-functioning kidney allograftW R Herzog, B Zanker, E Irschick, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Hyperimmunoglobulin prophylaxis, monitoring and preemptive ganciclovir treatment eliminate the risk of CMV infection to improve patient and renal allograft survivalH Schneeberger, S Aydemir, R Müller, et al.
Transplantation|July 29, 1998
Mycophenolate mofetil-based, cyclosporine-free induction and maintenance immunosuppression: first-3-months analysis of efficacy and safety in two cohorts of renal allograft recipientsB Zanker, H Schneeberger, U Rothenpieler, et al.
Pageof 3